2014年 · 第53卷第07期

enhanced external counterpulsation (EECP) is a non-invasive assisted circulation method for the treatment of ischemic diseases. It has been widely used in the treatment of ischemic heart disease and stroke in China since the late 1970s^[1,2]。 In 1992, the U.S. Food and Drug Administration (FDA) confirmed that EECP can be used for the treatment of stable and unstable angina pectoris, acute myocardial infarction and cardiogenic shock. In 2002, congestive heart failure was included in its indication. In 2013, the European Society of Cardiology included EECP therapy (Ⅱa) in the guidelines for the diagnosis and treatment of stable coronary heart disease^[3]。 Cardiovascular rehabilitation is to control cardiovascular risk factors, reduce symptoms, improve exercise tolerance and quality of life through comprehensive interventions, such as drugs, exercise, nutrition, education, psychological and lifestyle changes, so as to reduce acute cardiovascular events and cardiovascular related deaths. EECP can increase coronary blood flow, promote the formation of coronary collateral circulation, and improve exercise tolerance. Some scholars refer to EECP as a passive "movement".